STOCKHOLDERS’ EQUITY (Details Narrative)

v3.26.3

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)																				1 Months Ended	3 Months Ended					9 Months Ended			12 Months Ended
	Sep. 02, 2026	Aug. 18, 2026	Mar. 09, 2026	Mar. 04, 2026	Sep. 18, 2025	Jun. 17, 2025	Jun. 03, 2025	May 08, 2025	Mar. 03, 2025	Feb. 24, 2025	Dec. 13, 2024	Nov. 01, 2024	Apr. 25, 2024	Mar. 28, 2024	Mar. 14, 2024	Nov. 17, 2023	May 25, 2023	Aug. 03, 2022	Aug. 01, 2022	May 31, 2024	Sep. 30, 2026	Mar. 31, 2026	Sep. 30, 2025	Jun. 30, 2025	Mar. 31, 2025	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2024	Dec. 31, 2025	Jan. 01, 2026	May 22, 2025	Mar. 22, 2025	Jan. 01, 2025	Dec. 23, 2024	Mar. 25, 2024	Feb. 14, 2024	Jan. 01, 2024	Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized																			70,000,000		150,000,000					150,000,000			150,000,000		150,000,000
Preferred stock, shares authorized																			30,000,000		30,000,000					30,000,000			30,000,000		30,000,000
Common stock, par value																					$ 0.0001					$ 0.0001			$ 0.0001
Other issuance costs																						$ 1,995,041				$ 2,060,041	$ 498,429
Change in fair value of warrant liability																					$ (350,282)		$ (379,311)			(535,408)	(944,698)
Warrant liability classified instruments																					$ 956,987					956,987			$ 1,492,395
Proceeds from warrant exercise																											901,578
Stock options outstanding																					16,976,378					16,976,378			12,878,381
Options contractual term																										7 years
Percentage of shares granted																										10.00%
Exercise price percentage																										110.00%
2018 Stock Option Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Stock options outstanding																					1,752,945					1,752,945
Amended and Restated 2020 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Stock options outstanding																					3,503,589					3,503,589
Common stock reserved for issuance																					0					0
2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Stock options outstanding																					11,719,844					11,719,844
Common stock reserved for issuance																			1,909,518		2,770,566					2,770,566				6,458,889			2,250,000				2,838,668	1,956,993
Percentage of increase in stock outstanding fully diluted																	10.00%
PoC Capital LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued upon exercise of warrants	751,879
Commitment fund for clinical trial expenses	$ 1,000,000.0
Restricted Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Consulting expense																										$ 25,605	$ 31,570
Options granted																										19,834	18,040
Unvested shares																					0		0			0	0
Restricted Stock [Member] | Research Services [Member]
Subsidiary, Sale of Stock [Line Items]
Options granted																										242,255	58,425
Research and development expense																										$ 355,283	$ 118,064
Restricted Stock [Member] | Investor [Member]
Subsidiary, Sale of Stock [Line Items]
Consulting expense																										$ 100,000	$ 100,000
Options granted																										76,335	64,516
Share-Based Payment Arrangement, Option [Member]
Subsidiary, Sale of Stock [Line Items]
Volatility rate																										85.00%
Weighted-average grant date fair value																										$ 0.98	$ 1.62
Unrecognized compensation																					$ 5,294,145					$ 5,294,145
Unrecognized compensation expense, recognized period																										1 year 6 months 14 days
Performance Shares [Member] | 2021 Equity Incentive Plan [Member]
Subsidiary, Sale of Stock [Line Items]
Options granted		400,000	400,000
Weighted average exercise price		$ 1.37	$ 1.49
Performance Shares [Member] | 2021 Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Subsidiary, Sale of Stock [Line Items]
Options granted		100,000	100,000
Performance Shares [Member] | 2021 Equity Incentive Plan [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Subsidiary, Sale of Stock [Line Items]
Percentage of increase in stock outstanding fully diluted		5.00%	5.00%
Options granted		300,000	300,000
Investment amount		$ 10,000,000	$ 10,000,000
Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued upon exercise of warrants																							2,086,312	793,429	666,323
Representatives Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants value																		$ 343,735			2,542					$ 2,542			$ 27,455
Expected term																		5 years
Risk free interest rate																		2.82%
Volatility rate																		77.50%
Change in fair value of warrant liability																					2,736		$ 10,126			$ 24,913	$ 42,202
Maximum [Member]
Subsidiary, Sale of Stock [Line Items]
Options contractual term																										10 years
Maximum [Member] | Share-Based Payment Arrangement, Option [Member]
Subsidiary, Sale of Stock [Line Items]
Expected term																										6 years 29 days	6 years 29 days
At-The-Market Offering Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Other issuance costs																							117,136	$ 61,132	$ 130,220
Private Placement [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold							463,332	719,999	952,633	1,810,000
Sale of common stock, price per share							$ 1.50	$ 1.50	$ 1.50	$ 1.50	$ 2.08	$ 2.51
Other issuance costs																								$ 115,493	$ 74,448
Warrants issued to purchase common stock							463,332	719,999	952,633	1,810,000	507,364	1,079,784	494,096	578,643	2,496,318					437,031
Gross proceeds from private placement							$ 700,000	$ 1,080,000.00	$ 1,400,000	$ 2,700,000
Warrant exercise price per share							$ 1.71	$ 2.05	$ 1.85	$ 1.87			$ 2.26	$ 2.55	$ 1.30
Warrants term							5 years	6 years	6 years	6 years
Warrants expiration date							Jun. 03, 2030	May 08, 2031	Mar. 03, 2031	Feb. 24, 2031	Jun. 13, 2030	May 01, 2030	Oct. 25, 2029	Sep. 28, 2029	Sep. 14, 2029
Warrants exercisable date							Dec. 03, 2025	May 08, 2026	Mar. 03, 2026	Feb. 24, 2026	Jun. 13, 2025	May 01, 2025	Oct. 25, 2024	Sep. 28, 2024	Sep. 14, 2024
Warrants value														$ 1,190,111						$ 5,089,063
Expected term														5 years 6 months
Risk free interest rate														4.20%
Volatility rate														95.00%
Change in fair value of warrant liability																				769,671
Private Placement [Member] | Amendment of Warrant Agreements [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants value																				1,011,562	64,915					$ 64,915			$ 117,613
Change in fair value of warrant liability																					24,530		26,324			52,698	$ 76,387
Warrant liability classified instruments																				$ 141,612
Private Placement [Member] | Director [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock							33,333	86,666	58,333	123,333	78,418	232,800	167,157		452,731
Warrants value							$ 43,358	$ 133,131	$ 80,894	$ 176,680	$ 116,151	$ 494,851	$ 346,606		$ 230,685
Expected term							5 years	6 years	6 years	6 years	5 years 6 months	5 years 6 months	5 years 6 months		5 years 6 months
Risk free interest rate							4.04%	4.09%	3.97%	4.23%	4.25%	4.22%	4.70%		4.20%
Volatility rate							95.00%	95.00%	95.00%	95.00%	95.00%	95.00%	95.00%		95.00%
Private Placement [Member] | Non-affiliated Investors [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock							429,999	633,333	894,300		428,946	846,984	326,939		2,043,587
Warrants value							$ 559,324	$ 972,890	$ 1,240,185		$ 635,345	$ 1,800,389	$ 677,919		$ 2,049,600
Expected term							5 years	6 years	6 years		5 years 6 months	5 years 6 months	5 years 6 months		5 years 6 months
Risk free interest rate							4.04%	4.09%	3.97%		4.25%	4.22%	4.70%		4.20%
Volatility rate							95.00%	95.00%	95.00%		95.00%	95.00%	95.00%		95.00%
Private Placement [Member] | Investors [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued upon exercise of warrants																													12,291
Number of warrants exercised																													12,291
Private Placement [Member] | Investors One [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued upon exercise of warrants																													379,970
Number of warrants exercised																													379,970
Private Placement [Member] | Investors Two [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued upon exercise of warrants																													80,127
Number of warrants exercised																													80,127
Private Placement [Member] | Affiliated and Nonaffiliated Investor [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock										1,686,667
Warrants value										$ 2,416,223
Expected term										6 years
Risk free interest rate										4.23%
Volatility rate										95.00%
Confidentially Marketed Public Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Number of common stock sold			2,005,875	20,000,000
Sale of common stock, price per share			$ 1.50	$ 1.50
Gross proceeds from offering			$ 3,009,000	$ 30,000,000
Commissions paid			150,000	1,500,000
Other issuance costs			16,000	329,000
Net proceeds from offering			$ 2,843,000	$ 28,171,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock																			100,000
Warrant exercise price per share																			$ 6.25
Warrants expiration date																			Jul. 27, 2027
Warrants exercisable date																			Jan. 23, 2023
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock																		15,000
Registered Direct Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock																2,424,243
Warrant exercise price per share																$ 1.86
Shares issued upon exercise of warrants																												458,726
Warrants value																$ 1,903,915					824,660					824,660			$ 1,216,774
Expected term																5 years 4 months 17 days
Risk free interest rate																3.85%
Volatility rate																90.00%
Change in fair value of warrant liability																					294,566		299,584			392,114	733,027
Warrants exercised																												909,091
Increase in equity on exercise of warrant liability																$ 2,815,970
Registered Direct Offering One [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants issued to purchase common stock																169,697
Warrant exercise price per share																$ 2.06
Warrants expiration date																Nov. 15, 2028
Warrants exercisable date																Nov. 15, 2023
Warrants value																$ 123,811					64,870					64,870			$ 130,553
Expected term																4 years 10 months 17 days
Risk free interest rate																3.84%
Volatility rate																90.00%
Change in fair value of warrant liability																					$ 28,450		$ 43,277			$ 65,683	$ 93,082
Warrant Inducement Offer [Member]
Subsidiary, Sale of Stock [Line Items]
Warrant exercise price per share					$ 1.30	$ 1.50
Shares issued upon exercise of warrants					440,503	219,283
Change in fair value of warrant liability					$ 60,275	$ 105,154
Proceeds from warrant exercise					$ 572,654	$ 328,924
H.C. Wainwright & Co., LLC [Member] | At-The-Market Offering Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, par value																																				$ 0.0001
Number of common stock sold																									666,323
Sale of common stock, price per share																									$ 2.28
Gross proceeds from offering																									$ 1,521,091
Commissions paid																									45,633
Other issuance costs																									84,587
Net proceeds from offering																									$ 1,390,871
H.C. Wainwright & Co., LLC [Member] | At-The-Market Offering Agreement [Member] | Maximum [Member] | Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Aggregate offering price																																$ 11,200,000		$ 30,000,000	$ 4,950,000	$ 1,445,000